当前位置:首页 > 报告详情

肾癌遗传风险人群筛查现状.pdf

上传人: 明**** 编号:1012407 2025-12-21 17页 1.80MB

1、The State of Screening Individuals with a Hereditary Risk of Kidney CancerMarie Carlo,MDGenitourinary Oncology Medical GeneticsMemorial Sloan Kettering Cancer Center Learning Objectives Distinguish patients to refer genetic risk evaluation of hereditary RCC Evaluate real world evidence of germline t

2、esting for RCC Emerging genetic and clinical associations with RCC39-year-old woman,healthyIncidental renal mass-nephrectomy shows clear cell RCC,T2,grade 2 No family history of RCC Do you offer germline genetic evaluation?Guidelines for Genetic Evaluation NCCN 2025AUA 2021Age 46 46MultifocalityYesY

3、esFamily HistoryRelative RCC Relative RCC or syndromePathologySuggestive of a syndromeSuggestive of a syndromeCampbell et al.Journal of Urology,2021.Motzer et al.NCCN 2025.“should recommend”“consider referral”Young Onset RCCShiels et al.Cancer Discovery,2025.Largest absolute increases:breast(n=4,834

4、 additional cancers)colorectal(n=2,099)kidney(n=1,793)uterine cancers(n=1,209)Young Onset RCCTruong et al.EU Oncology,2021.Young Onset RCCTruong et al.EU Oncology,2021.Guidelines for Genetic Evaluation NCCN 2025AUA 2021Age 46 46MultifocalityYesYesFamily HistoryRelative RCC Relative RCC or syndromePa

5、thologySuggestive of a syndromeSuggestive of a syndromeCampbell et al.Journal of Urology,2021.Motzer et al.NCCN 2025.“should recommend”“consider referral”Guidelines for Genetic Evaluation NCCN 2025AUA 2021Age 46 46MultifocalityYesYesFamily HistoryRelative RCC Relative RCC or syndromePathologySuggest

6、ive of a syndromeSuggestive of a syndromePersonal or family history of mesothelioma/uveal melanomaCampbell et al.Journal of Urology,2021.Motzer et al.NCCN 2025.“should recommend”“consider referral”BAP1 Tumor Predisposition Syndrome Autosomal dominant 85%lifeti

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据标记内容,全文主要关于肾癌遗传风险评估和基因检测: 1. 遗传风险评估指南:NCCN 2025和AUA 2021指南建议对年龄≤46岁、多灶性肾癌、有家族史或病理提示综合征的患者进行遗传风险评估。 2. 遗传性肾癌风险增加:年轻发病的肾癌患者中,乳腺癌、结直肠癌、肾癌和子宫癌的风险显著增加。 3. BAP1肿瘤易感综合征:BAP1突变导致85%的终身癌症风险,与多种癌症相关。 4. CHEK2基因变异:c.1100delC变异与乳腺癌风险增加相关,但具体影响尚需进一步研究。 5. 基因检测在肾癌中的应用:尽管存在,但基因检测在年轻透明细胞肾癌患者中的低发病率限制了其实际应用。
"遗传肾癌筛查指南" "年轻肾癌患者基因检测" "BAP1和CHEK2突变与肾癌关联"
客服
商务合作
小程序
服务号
折叠